First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
More stories
Workers' Comp
Article
Elevating Work Comp Care Through Physical Medicine Innovation
When it comes to physical therapy (PT), ensuring injured employees receive timely, effective care can be critical to recovery.
Workers' Comp
News Release
Enlyte’s 2025 Trends Report Examines ‘The Year of Generative AI’
Industry leaders discuss impact on the growing utilization of gen AI and data analytics as well as strategies addressing clinical and auto cha
Workers' Comp
Article
Specialty Solutions Spotlight: How Bone Growth Stimulators Accelerate Healing
Who is best suited to use a bone growth stimulator after an injury?Recovering from a broken bone can be a long and difficult journey, ofte
Workers' Comp
Article
Functional Capacity Evaluation (FCE) Frequently Asked Questions
What is a Functional Capacity Evaluation (FCE)?An FCE is a comprehensive assessment used to determine an individual's physical
Workers' Comp
Case Study
Clinical Oversight Reduces Claim Costs by Recommending Discharge Over Added PT
Workers' Comp
Article
Workers' Compensation Pharmacy Legislative and Regulatory End of Year Recap
New regulations, proposed legislation, and notable judicial developments made 2024 a significant year for workers' compensation pharmacy programs.